Kainos Medicine Inc (284620) - Cash Flow Conversion Efficiency

Latest as of March 2025: -0.551x

Based on the latest financial reports, Kainos Medicine Inc (284620) has a cash flow conversion efficiency ratio of -0.551x as of March 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-2.97 Billion ≈ $-2.01 Million USD) by net assets (₩5.40 Billion ≈ $3.66 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Kainos Medicine Inc - Cash Flow Conversion Efficiency Trend (2017–2024)

This chart illustrates how Kainos Medicine Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read total liabilities of Kainos Medicine Inc for a breakdown of total debt and financial obligations.

Kainos Medicine Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Kainos Medicine Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Innodep Inc. KQ:303530	-0.187x
Sin-Kung Logistics Berhad KLSE:0305	0.042x
Avenira Ltd AU:AEV	-0.083x
Wing Yip Food (China) Holdings Group Limited KQ:900340	-0.005x
Bambuser AB ST:BUSER	-0.182x
Netgem SA PA:ALNTG	0.056x
UCAL Limited NSE:UCAL	N/A
Melbana Energy Ltd AU:MAY	-0.017x

Annual Cash Flow Conversion Efficiency for Kainos Medicine Inc (2017–2024)

The table below shows the annual cash flow conversion efficiency of Kainos Medicine Inc from 2017 to 2024. For the full company profile with market capitalisation and key ratios, see 284620 stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩1.79 Billion ≈ $1.21 Million	₩-9.71 Billion ≈ $-6.58 Million	-5.430x	-348.73%
2023-12-31	₩11.75 Billion ≈ $7.96 Million	₩-14.22 Billion ≈ $-9.64 Million	-1.210x	-179.71%
2022-12-31	₩26.11 Billion ≈ $17.69 Million	₩-11.30 Billion ≈ $-7.66 Million	-0.433x	+43.05%
2021-12-31	₩12.10 Billion ≈ $8.20 Million	₩-9.20 Billion ≈ $-6.23 Million	-0.760x	-23.35%
2020-12-31	₩12.35 Billion ≈ $8.37 Million	₩-7.61 Billion ≈ $-5.16 Million	-0.616x	-3385.22%
2019-12-31	₩9.91 Billion ≈ $6.71 Million	₩185.74 Million ≈ $125.88K	0.019x	+937.07%
2018-12-31	₩9.83 Billion ≈ $6.66 Million	₩-22.01 Million ≈ $-14.92K	-0.002x	+92.18%
2017-12-31	₩950.59 Million ≈ $644.20K	₩-27.23 Million ≈ $-18.45K	-0.029x	--

About Kainos Medicine Inc

KQ:284620 Korea Biotechnology

Market Cap

$24.10 Million

₩35.56 Billion KRW

Market Cap Rank

#24450 Global

#1799 in Korea

Share Price

₩1087.00

Change (1 day)

-8.81%

52-Week Range

₩977.00 - ₩1270.00

All Time High

₩28151.21